Roy Cleeland
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 27
- Antibiotics Pharmacokinetics and Efficacy 27
- Epidemiology 25
- Urinary Tract Infections Management 8
- Influenza Virus Research Studies 8
- Respiratory viral infections research 6
- Co-authors
- E. Grunberg (24 shared papers)Barbara Prosser (10 shared papers)G. Beskid (19 shared papers)W. F. DeLorenzo (7 shared papers)Michael Krämer (4 shared papers)James G. Christenson (5 shared papers)Dennis D. Keith (5 shared papers)Silvano De Bernardo (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (14 papers)The American Journal of Medicine (4 papers)International Journal of Antimicrobial Agents (4 papers)Chemotherapy (4 papers)Experimental Biology and Medicine (4 papers)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Roy Cleeland
64 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 108
- Molecular Medicine 254
- Pharmacology 329
- Microbiology 85
- Clinical Biochemistry 71
- Toxicology 35
Countries citing papers authored by Roy Cleeland
This map shows the geographic impact of Roy Cleeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Cleeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Cleeland more than expected).
Fields of papers citing papers by Roy Cleeland
This network shows the impact of papers produced by Roy Cleeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Cleeland. The network helps show where Roy Cleeland may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy Cleeland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 173 | |
| 2 | 1973 | 69 | |
| 3 | Antimicrobial activity of ceftriaxone: a review. | 1984 | 56 |
| 4 | 1990 | 55 | |
| 5 | 1976 | 53 | |
| 6 | 2005 | 48 | |
| 7 | 1976 | 45 | |
| 8 | 1989 | 41 | |
| 9 | 1993 | 40 | |
| 10 | 1976 | 37 | |
| 11 | 1973 | 37 | |
| 12 | 1981 | 34 | |
| 13 | 1992 | 34 | |
| 14 | 1989 | 32 | |
| 15 | 1996 | 27 | |
| 16 | 1989 | 24 | |
| 17 | 1994 | 24 | |
| 18 | 1977 | 24 | |
| 19 | 1982 | 24 | |
| 20 | Antiprotozoan and antibacterial activity of 2-nitroimidazole derivatives. | 1967 | 22 |
About Roy Cleeland
Roy Cleeland is a scholar working on Pharmacology, Epidemiology, Molecular Medicine, Molecular Biology and Infectious Diseases, having authored 67 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (27 papers), Antibiotic Resistance in Bacteria (21 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Cancer therapeutics and mechanisms (10 papers), Urinary Tract Infections Management (8 papers), Influenza Virus Research Studies (8 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Respiratory viral infections research (6 papers). The work is most often cited by research in Molecular Medicine (254 citations), Pharmacology (329 citations), Microbiology (85 citations), Clinical Biochemistry (71 citations) and Toxicology (35 citations). Roy Cleeland has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include E. Grunberg, Barbara Prosser, G. Beskid, W. F. DeLorenzo, Michael Krämer, James G. Christenson, Dennis D. Keith, Silvano De Bernardo, Manfred Weigele and W. Leimgruber. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The American Journal of Medicine, International Journal of Antimicrobial Agents, Chemotherapy and Experimental Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.